| Trial ID: | L1701 |
| Source ID: | NCT02324686
|
| Associated Drug: |
Vitamin K1
|
| Title: |
Vitamin K Supplementation in Patients on Hemodialysis
|
| Acronym: |
VISTA
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
End Stage Renal Failure on Dialysis|Atrial Fibrillation
|
| Interventions: |
DRUG: vitamin K1
|
| Outcome Measures: |
Primary: INR stability (standard deviation of INR values), standard deviation of INR values, 4 months before and 4 months after the intervention, 4 months before and 4 months after intervention | Secondary: Time in Therapeutic Range (Percentage of time INR levels within range), , 4 months before and 4 months after the intervention, 4 months before and 4 months after intervention|Adverse events, Number and types of thromboembolic and bleeding complications, 4 months before and 4 months after the intervention, 4 months before and 4 months after intervention
|
| Sponsor/Collaborators: |
Sponsor: University Health Network, Toronto
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
3
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-01
|
| Completion Date: |
2017-12-18
|
| Results First Posted: |
|
| Last Update Posted: |
2018-02-06
|
| Locations: |
University Health Network, Toronto, Ontario, M5G 2C4, Canada
|
| URL: |
https://clinicaltrials.gov/show/NCT02324686
|
